Neuralink
This company is in the pipeline of America 2030, IPO CLUB’s short-term, actively managed secondary fund focused on U.S. defense, energy, security, and AI.
Updated in January 2026
Headquarter: Fremont, California, USA
Year Founded: 2016
Leadership: Elon Musk
Industry Sectors: Neurotechnology; Brain–computer interfaces; Medical devices; Artificial intelligence
Funding Round: ~$323M Series D (2023)
Valuation: ~$5B
Is Neuralink A Public Company? No, it is currently private
What Is Neuralink?
Neuralink is a U.S.-based neurotechnology company founded in 2016 by Elon Musk and a team of engineers and neuroscientists, with headquarters in Fremont, California. The company’s mission is to develop implantable brain–computer interfaces (BCIs) that enable direct communication between the human brain and computers, initially to help people with severe neurological conditions regain lost capabilities. Neuralink positions its work at the intersection of neuroscience, robotics, and artificial intelligence, aiming to create high-bandwidth, minimally invasive neural interfaces.
Technology & Products
Neuralink’s core technology is an implantable BCI system consisting of a small brain implant (often referred to as the Link), ultra-thin flexible electrode threads, and a precision surgical robot designed to insert the threads into the brain with high accuracy while avoiding blood vessels. The implant records neural signals and transmits them wirelessly to external devices, where software decodes the signals into actionable commands. Early human applications focus on enabling individuals with paralysis to control computers and digital interfaces using thought alone, with longer-term ambitions including restoring sensory function and treating neurological disorders.
Market Opportunity
Neuralink operates within the emerging brain–computer interface and neuroprosthetics market, which addresses significant unmet needs in paralysis, spinal cord injury, neurodegenerative disease, and assistive communication. Initial target users include patients with severe motor impairments, a population representing a meaningful clinical and commercial opportunity given the lack of effective alternatives. Over time, broader applications in rehabilitation, neurology, and human–computer interaction could expand the addressable market substantially, particularly as regulatory approvals and clinical evidence progress.
Competitive Landscape
Neuralink competes with other BCI and neurotechnology companies, including academic spinouts and established medical device firms developing invasive and non-invasive neural interfaces. Its primary differentiators are the high channel count of its implants, the robotic, scalable surgical approach, and strong vertical integration across hardware, software, and surgery. While competitors may be further along in certain clinical indications, Neuralink’s ambition and technical scope position it as a high-risk, high-impact player in the next generation of neural interface technologies.
How To Buy Neuralink Stock?
Neuralink is currently a private company and is not publicly traded on major stock exchanges like the NASDAQ or NYSE. This means you can buy shares through a pre-IPO platform or brokerage like IPO CLUB by becoming a FREE MEMBER.
Courtesy of Neuralink
This company is in the pipeline of America 2030, IPO CLUB’s short-term, actively managed secondary fund focused on U.S. defense, energy, security, and AI.
FAQ
Last updated:
How can I invest in Neuralink pre-IPO through IPO CLUB?
Neuralink access on IPO CLUB is typically offered to accredited investors via curated secondary allocations, including the America 2030 Fund and Single-Name SPVs.
- You need to qualify as an accredited investor to participate.
- Availability depends on secondary supply and seller willingness.
- Access is provided through the America 2030 Fund or Single-Name SPVs.
Do you currently have access to Neuralink shares?
Neuralink availability on IPO CLUB can change and is generally limited to Single-Name SPVs.
- To check if Neuralink is currently on offer, register or log in to the IPO CLUB membership area and open Live Deals.
- Secondary allocations may open or close depending on seller participation.
- Access is provided through the America 2030 Fund or Single-Name SPVs.
Is Neuralink publicly traded, and does it have a stock ticker?
Neuralink is private and does not have a public stock ticker, so IPO CLUB access (for accredited investors) is typically via curated secondary allocations like the America 2030 Fund and Single-Name SPVs.
- There is no public-market quote or ticker for Neuralink.
- Transactions, if available, are generally secondary and may be illiquid.
- Access is provided through the America 2030 Fund or Single-Name SPVs.
When is the Neuralink IPO?
Neuralink has no confirmed IPO date, so IPO CLUB access for accredited investors is generally focused on curated secondary allocations through the America 2030 Fund and Single-Name SPVs.
- No IPO date is guaranteed or required for a secondary allocation.
- Timing can depend on market conditions and company decisions.
- Access is provided through the America 2030 Fund or Single-Name SPVs.
What security types are typically used for Neuralink transactions on IPO CLUB?
Neuralink exposure on IPO CLUB is typically provided to accredited investors through structured vehicles such as the America 2030 Fund and Single-Name SPVs used for curated secondary allocations.
- Single-Name SPVs are commonly used to pool investor participation.
- Member exposure is to an interest in the relevant vehicle, not necessarily direct shares.
- Final structure can vary by allocation and seller terms.
What are the risks of buying Neuralink pre-IPO shares?
Neuralink pre-IPO investing can be illiquid and high-risk, and IPO CLUB access is limited to accredited investors via curated secondary allocations through the America 2030 Fund and Single-Name SPVs.
- Liquidity risk: you may not be able to sell quickly or at a desired price.
- Execution risk: transfers can be delayed or blocked by restrictions.
- Timing risk: there may be no IPO or liquidity event on a predictable schedule.
Why might a Neuralink allocation not be confirmed?
Neuralink allocations can fail to confirm due to limited secondary supply, transfer restrictions, or changing seller terms.
- Supply can be oversubscribed or withdrawn by sellers.
- Transfer approvals or documentation issues can prevent closing.
- Allocation sizing can change based on final secondary availability.
Neuralink is developing a fully-implanted, wireless, high-channel count brain-machine interface (BMI) with the goal of enabling people with paralysis to directly use their neural activity to operate computers and mobile devices with speed and ease.
Neuralink and America 2030 Latest News
Stay up-to-date with all the latest news about Neuralink stock, the IPO, and investment opportunities. By clicking here, you'll access real-time updates and in-depth analysis from market experts, empowering you to make informed decisions about your investment journey. Whether you're a seasoned investor or just getting started, our platform is tailored to provide you with all the crucial information you need to navigate the thrilling world of the stock market and IPOs. Dive in and keep your finger on the pulse of the financial markets.
October Update on Live Investments, Covering the Previous 90 Days